Dyne Therapeutics, Inc. (DYN)
19.59
+0.32
(+1.66%)
USD |
NASDAQ |
Dec 15, 16:00
19.59
0.00 (0.00%)
After-Hours: 20:00
Dyne Therapeutics Research and Development Expense (Quarterly): 97.22M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Avidity Biosciences, Inc. | 154.95M |
| Biogen, Inc. | 369.60M |
| AbbVie, Inc. | 2.319B |
| Kymera Therapeutics, Inc. | 71.94M |
| Structure Therapeutics, Inc. | 59.07M |